Central nervous system drugs

Amino Acid Sequence Arg-Gly-Glu-Ser Application Arg-Gly-Glu-Ser acetate salt has been used: as an integrin blocking peptide to study its effects on ciliary neurotrophic factor (CNTF) regulation in astroglioma cells as a control peptide to study its

Amino Acid Sequence Arg-Gly-Glu-Ser Application Arg-Gly-Glu-Ser acetate salt has been used: as an integrin blocking peptide to study its effects on ciliary neurotrophic factor (CNTF) regulation in astroglioma cells as a control peptide to study its

InformationArgireline is an innovative neuropeptide widely applied topically on the skin.

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the

ARL 17477 dihydrochloride is a selective NOS1 (nNOS) inhibitor with IC|50|values of 1 and 17 μM for NOS1 and NOS3, respectively. This compound has been shown to reduce ischemic cell damage after middle cerebral artery (MCA) occlusion in rats.

ARL 17477 dihydrochloride is a selective NOS1 (nNOS) inhibitor with IC|50|values of 1 and 17 μM for NOS1 and NOS3, respectively. This compound has been shown to reduce ischemic cell damage after middle cerebral artery (MCA) occlusion in rats.

Application ARL-17477 dihydrochloride hydrate may be used in cell signaling studies. Biochem/physiol Actions ARL-17477 is an nNOS specific inhibitor.

InformationARRY-382 is a potent, oral and highly selective inhibitor of c-Fms tyrosine kinase(CSF1R) with IC50 of 9 nM.

InformationARS-853 (ARS853) ARS-853 is a selective, covalent KRAS(G12C) inhibitor that inhibits mutant KRAS-driven signaling by binding to the GDP-bound oncoprotein and preventing activation. ARS-853 also induces apoptosis .TargetsK-Ras(G12C) (in

InformationARS-853 (ARS853) ARS-853 is a selective, covalent KRAS(G12C) inhibitor that inhibits mutant KRAS-driven signaling by binding to the GDP-bound oncoprotein and preventing activation. ARS-853 also induces apoptosis .TargetsK-Ras(G12C) (in

InformationARS-853 (ARS853) ARS-853 is a selective, covalent KRAS(G12C) inhibitor that inhibits mutant KRAS-driven signaling by binding to the GDP-bound oncoprotein and preventing activation. ARS-853 also induces apoptosis .TargetsK-Ras(G12C) (in

InformationARS-853 (ARS853) ARS-853 is a selective, covalent KRAS(G12C) inhibitor that inhibits mutant KRAS-driven signaling by binding to the GDP-bound oncoprotein and preventing activation. ARS-853 also induces apoptosis .TargetsK-Ras(G12C) (in